FEMASYS
Femasys is a biomedical company focused on transforming women’s healthcare worldwide by developing novel solutions and next-generation advancements providing significant clinical impact to address severely underserved areas. With an initial focus in the area of reproductive health, its two lead product candidates offer solutions to improve patient care and health economics: FemBloc, a first and only non-surgical product for permanent birth control and FemaSeed, a first and only directed sperm ... delivery product for infertility treatment. Femasys’ FemVue product for fallopian tube assessment by ultrasound is currently marketed in the United States as its main commercial priority. Femasys has also developed a novel technology platform for tissue sampling intended to be marketed alongside our other women-specific medical products in the physician’s office setting.
FEMASYS
Industry:
Biotechnology Health Care Manufacturing Medical Device Robotics Women's
Founded:
2004-01-01
Address:
Suwanee, Georgia, United States
Country:
United States
Website Url:
http://www.femasys.com
Total Employee:
51+
Status:
Active
Contact:
1(770) 500-3910
Email Addresses:
[email protected]
Total Funding:
63.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
AEGEA Medical
AEGEA Medical manufactures surgical and medical instruments.
AOT - Advanced Osteotomy Tools
Advanced Osteotomy Tools engages in the development of medical devices for advanced osteotomy.
Atomo Diagnostics
Atomo Diagnostics design and manufactures blood-based, lateral flow rapid diagnostic test (RDT) devices.
Basecare
Basecare is a manufacturing devices for embryonic pre-implantation genetic screening.
Biom'Up
Biom'Up is a French company that specialises in the manufacture of re-absorbable medical devices based on collagen technology.
Bionik Laboratories
Bionik Laboratories is an innovative medical device and robotics company
BiVACOR
BiVACOR designs and manufactures centrifugal heart pumps.
Colorado Therapeutics
Advancements in crosslinking technology for soft tissue repair
Cruzar Medsystems
Cruzar Medsystems operates in the healthcare industry manufacturing medical device designed to access peripheral vasculature.
DJO Global
DJO Global is a manufacturer and distributor of medical devices for musculoskeletal health, vascular health, and pain management.
Enable Injections
Enable Injections designs and produces on-body delivery systems that allow patients to self-administer large amounts of medication.
Wellsense
Wellsense develops and manufactures medical devices to provide hospitals to enhance their standard of care.
Global Good
Global Good designs and manufactures high-tech medical devices for specialized health care professionals.
Healthium Medtech
Healthium MedTech manufactures and sells a broad range of medical devices and consumable products.
Ideal Implant
Ideal Implant engages in the development, manufacture, and marketing of saline-filled breast implants for women.
Inogen
Inogen is a manufacturer and an accredited homecare provider dedicated to oxygen therapy.
JoyMed Technology
JoyMed Technology is a designer and manufacturer of medical devices.
Medicreations
Medicreations is a manufacturer of medical devices for practitioners.
Motion Composites
Motion Composites is an innovative light-weight carbon wheelchair company.
Norman Biological Technology
Norman Biological Technology is a manufacturer of automated chemiluminescence system.
Opus Medical
Opus Medical designs and manufactures medical devices for use in motion management during cancer treatment.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Rainjet
Rainjet engages in the R&D and manufacturing of medical equipment.
Sabona
Sabona is the first-class manufacturer of magnetic bracelets, cable twist bracelets and copper magnetic bracelets.
Skanray Technologies
Skanray Technologies is a medical equipment manufacturing company specializing in x-ray imaging systems and critical care devices.
Spine Wave
Spine Wave engages in developing and marketing medical devices for the treatment of spinal disorders.
Stel Life
Stel Life simplifies health device connectivity for patients, care teams, and device companies.
YOUNG-IN biotech
YOUNG-IN biotech engages in the R&D and manufacturing of medical, aesthetic and healthcare devices.
Yunzhou Intelligence Technology
Zhuhai Yunzhou Intelligence Technology Ltd. manufactures and markets unmanned surface vehicles (USV) for the water monitoring industry.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Legacy Capital Partners
Legacy Capital Partners investment in Series B - Femasys
Mario Family Funds
Mario Family Funds investment in Series B - Femasys
Salem Partners
Salem Partners investment in Series B - Femasys
Official Site Inspections
http://www.femasys.com Semrush global rank: 2.08 M Semrush visits lastest month: 9.98 K
- Host name: 172.67.74.229
- IP address: 172.67.74.229
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Femasys"
Leadership | Femasys
As a woman-founded and led company with in-house manufacturing capabilities of its internally conceived portfolio of products, Femasys is well-positioned to deliver its solutions to the …See details»
Who We Are - Femasys
Femasys is committed to providing women with revolutionary products as they seek solutions throughout their reproductive journey. Technological advancements in female reproductive …See details»
Femasys Inc. - LinkedIn
Femasys is a biomedical company focused on transforming women’s healthcare worldwide by developing novel solutions and next-generation advancements providing significant clinical impact to ...See details»
Femasys - Crunchbase Company Profile & Funding
Femasys’ FemVue product for fallopian tube assessment by ultrasound is currently marketed in the United States as its main commercial priority. Femasys has also developed a novel …See details»
Investor Relations - Femasys Inc.
6 days ago Femasys Inc. is a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies …See details»
Femasys - Org Chart, Teams, Culture & Jobs - The Org
View Femasys' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in …
Nov 28, 2023 - Topline results from FemaSeed ® pivotal trial expected in 1H 2024 - - Commercial launch planned for early 2024 - ATLANTA, Nov. 28, 2023 (GLOBE NEWSWIRE) - …See details»
Femasys’ FemaSeed Localized Directional Insemination for …
Apr 18, 2023 - FemaSeed ® is the first-ever, first-line approach designed to deliver sperm directly where conception occurs -. ATLANTA, April 18, 2023 (GLOBE NEWSWIRE) -- …See details»
Femasys Completes the First In-Office Commercial Procedure with …
ATLANTA, March 06, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting the significant unmet needs for women worldwide …See details»
Resources - Femasys
Resources Find the latest news about Femasys, including our media mentions, scientific publications, and more. All 2021 2022 2023 2024 Video 08/30/2024 Medi ...See details»
Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First …
Feb 28, 2024 -- Femasys readies for the commercial launch of FemaSeed® in the U.S. amidst the uncertainty following the Alabama Supreme Court Ruling on how to handle embryos used …See details»
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University …
ATLANTA, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad …See details»
Femasys Inc. Receives U.S. FDA Clearance to Market FemaSeed
Sep 25, 2023 Femasys’ FemBloc® permanent birth control in late-stage clinical development is the first and only non-surgical, in-office, permanent birth control method intended to be a safer …See details»
Femasys Inc. Announces First Patient Treated in Pivotal Trial for ...
Jul 20, 2021 First in Class Insemination Treatment for Infertility LOCAL Pivotal Trial to Enroll Up to 792 Patients Across 20 U.S. Centers ATLANTA, July 20, 2021 (GLOBE NEWSWIRE) - …See details»
Infertility - Femasys
Femasys has achieved global regulatory approvals for a first-line infertility treatment and complimentary diagnostic products. Infertility More than 10 million women contend with …See details»
The Latest Analyst Ratings For Femasys - Nasdaq
5 days ago Analysts have set 12-month price targets for Femasys, revealing an average target of $11.2, a high estimate of $12.00, and a low estimate of $8.00.See details»
Birth Control - Femasys
FemBloc features our proprietary delivery platform, which places balloon technology close to the opening of both fallopian tubes. This in-office approach is designed to eliminate the risks of …See details»
Femasys Inc. Announces Financial Results for the Third Quarter of …
Nov 10, 2021 - Up to 792-patient, pivotal LOCAL trial progressing for FemaSeed ® after receipt of investigational device exemption (IDE) submission approval - - Femasys added to the …See details»
Femasys Inc. (FEMY) Stock Price, News, Quote & History - Yahoo …
Find the latest Femasys Inc. (FEMY) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»